Cerebrospinal fluid (CSF) xanthochromia, when diagnosed with spectrophotometry, is highly sensitive and specific for subarachnoid hemorrhage. However, most laboratories in North America currently rely on visual inspection rather than spectrophotometry for assessment of xanthochromia, making it less specific for the presence of hemoglobin degradation products and inclusive of other etiologies for yellow discoloration of the cerebrospinal fluid.
We present a series of cases from our inner-city community hospital to demonstrate how CSF xanthochromia is not specific to subarachnoid hemorrhage. There are three patients who presented with yellow-colored CSF but were ultimately diagnosed with meningitis or leptomeningeal carcinomatosis and one patient who presented with pink-colored CSF and was diagnosed with a true aneurysmal bleed.
Subarachnoid hemorrhage is a life-threatening emergency that is always on an emergency physician's list of differential diagnoses in a patient with acute headache. Our series of cases suggest the importance of correctly interpreting lumbar puncture findings and relying on spectrophotometry rather than visual inspection of the CSF to rule xanthochromia—and, consequently, subarachnoid hemorrhage—in or out.
Ethylene glycol is a toxic alcohol, and its ingestion can cause neurological, cardiovascular, and renal complications, including coma and death. It causes an elevated osmolar gap, and its metabolites, glycolate, and oxalate, are responsible for elevated anion gap metabolic acidosis. Early diagnosis and management of this condition are critical in the emergency department (ED).
The point-of-care (POC) blood gas analyzer, commonly used in the emergency department, measures lactic acid using the lactate oxidase method, which measures the hydrogen peroxide generated from lactate. In contrast, the laboratory analyzer measuring venous lactate uses the lactate dehydrogenase method. Glycolic acid, a metabolite of ethylene glycol, is structurally similar to L-lactic acid, and it cross-reacts with lactate on the POC analyzer. Glycolic acid metabolized by lactate oxidase also leads to increased hydrogen peroxide production similar to L-lactic acid, resulting in spuriously elevated lactate. This discrepancy causes higher lactate levels in POC measurement than the laboratory-measured lactate, a condition called lactate gap.
We present two patients with altered levels of consciousness who had elevated osmolar gap and lactate gap at presentation to the emergency department. Ethylene glycol poisoning was suspected, given the discrepancy between POC lactate and laboratory-measured venous lactate levels. We promptly initiated treatment with fomepizole and hemodialysis while waiting for ethylene glycol levels, prompting early recovery.
We hypothesize that ED physicians should use the lactate gap as an initial diagnostic tool for early diagnosis of ethylene glycol poisoning, and hospitalists and nephrologists can use the closure of the lactate gap to decide on dialysis termination.
Opioid drug overdose deaths are at an all-time high. Buprenorphine, a medication used to treat opioid use disorder, has dramatic effects on mortality after overdose as well as engagement with outpatient treatment programs. Recent regulatory changes have eased barriers to prescription, yet buprenorphine is infrequently prescribed from the emergency department. Objectives: Emergency physicians see patients who would benefit from this medication on a regular basis. We aim to illustrate how buprenorphine can be initiated from the emergency department.
Using a series of six cases, the use of buprenorphine for common presentations of patients with opioid use disorder (OUD) is described.
We present a series of clinical vignettes in order to increase emergency physicians’ familiarity and comfort with the use of buprenorphine/naloxone in the treatment of OUD. Patients with OUD treated with buprenorphine/naloxone are less likely to die from overdose and more likely to engage in long-term treatment. Emergency departments are well suited to initiate buprenorphine/naloxone for patients who are ready for change and eligible for medications for OUD. Now that barriers to prescribing have been removed, emergency clinicians should seek out patients with opioid use disorder who may benefit from this life-saving treatment, initiated either in the ED or at home.